Furthermore, the hub genes SLPI and MMP9 showed close association with immune cell infiltration in CAVD, implying that the candidate biomarkers might not only distinguish CAVD but also contribute to CAVD by interaction with inflammatory-immune pathways. The gene discussed is MMP9; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.